Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
| ▸ | GLB1 | P16278 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21322291 | 1.00 | HTT (0.37) | HTTEPHX2CCNT1CDK9EPHX1 | |
| SCHEMBL21290459 | 0.85 | HTT (0.34) | HTTEPHX1KDM4E | |
| SCHEMBL19735092 | 0.81 | ALDH1A1 (0.40) | EPHX2CCNT1CDK9GLB1CYP2C19 | |
| SCHEMBL24972574 | 0.79 | HTT (0.31) | HTT | |
| SCHEMBL26313845 | 0.79 | HTT (0.31) | HTT | |
| SCHEMBL25769714 | 0.79 | HTT (0.31) | HTT | |
| SCHEMBL3726725 | 0.76 | — | — | |
| SCHEMBL27282439 | 0.76 | GLB1 (0.36) | HTTEPHX1MEN1KMT2AKDM4E | |
| SCHEMBL23711913 | 0.76 | GLB1 (0.36) | HTTEPHX1MEN1KMT2AKDM4E | |
| SCHEMBL27281270 | 0.76 | GLB1 (0.36) | HTTEPHX1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019160882-A1 | PD-1/PD-L1 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2019-08-22 | — | — | WO | disclosed |